These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice. Takahashi S; Luo Y; Ranjit S; Xie C; Libby AE; Orlicky DJ; Dvornikov A; Wang XX; Myakala K; Jones BA; Bhasin K; Wang D; McManaman JL; Krausz KW; Gratton E; Ir D; Robertson CE; Frank DN; Gonzalez FJ; Levi M J Biol Chem; 2020 Apr; 295(14):4733-4747. PubMed ID: 32075905 [TBL] [Abstract][Full Text] [Related]
23. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695 [TBL] [Abstract][Full Text] [Related]
24. Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis Fernández-Ramos D; Lopitz-Otsoa F; Delacruz-Villar L; Bilbao J; Pagano M; Mosca L; Bizkarguenaga M; Serrano-Macia M; Azkargorta M; Iruarrizaga-Lejarreta M; Sot J; Tsvirkun D; van Liempd SM; Goni FM; Alonso C; Martínez-Chantar ML; Elortza F; Hayardeny L; Lu SC; Mato JM World J Gastroenterol; 2020 Sep; 26(34):5101-5117. PubMed ID: 32982112 [TBL] [Abstract][Full Text] [Related]
25. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. Nagaya T; Tanaka N; Kimura T; Kitabatake H; Fujimori N; Komatsu M; Horiuchi A; Yamaura T; Umemura T; Sano K; Gonzalez FJ; Aoyama T; Tanaka E BBA Clin; 2015 Jun; 3():168-74. PubMed ID: 26674248 [TBL] [Abstract][Full Text] [Related]
26. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis. Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243 [TBL] [Abstract][Full Text] [Related]
27. Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis. Huang C; Liu Q; Tang Q; Jing X; Wu T; Zhang J; Zhang G; Zhou J; Zhang Z; Zhao Y; Huang H; Xia Y; Yan J; Xiao J; Li Y; He J Free Radic Biol Med; 2021 Jun; 169():110-121. PubMed ID: 33857628 [TBL] [Abstract][Full Text] [Related]
32. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. Kim M; Yoo G; Randy A; Kim HS; Nho CW Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809 [TBL] [Abstract][Full Text] [Related]
33. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis. Suga T; Yamaguchi H; Ogura J; Shoji S; Maekawa M; Mano N Toxicol Appl Pharmacol; 2019 Sep; 379():114664. PubMed ID: 31306673 [TBL] [Abstract][Full Text] [Related]
34. Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Kong M; Zhu L; Bai L; Zhang X; Chen Y; Liu S; Zheng S; Pandol SJ; Han YP; Duan Z Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(9):G883-93. PubMed ID: 25214402 [TBL] [Abstract][Full Text] [Related]
35. Modeling human nonalcoholic steatohepatitis-associated changes in drug transporter expression using experimental rodent models. Canet MJ; Hardwick RN; Lake AD; Dzierlenga AL; Clarke JD; Cherrington NJ Drug Metab Dispos; 2014 Apr; 42(4):586-95. PubMed ID: 24384915 [TBL] [Abstract][Full Text] [Related]
36. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice. Fuchs CD; Krivanec S; Steinacher D; Mlitz V; Wahlström A; Stahlman M; Claudel T; Scharnagl H; Stojakovic T; Marschall HU; Trauner M Liver Int; 2020 Jun; 40(6):1366-1377. PubMed ID: 32141703 [TBL] [Abstract][Full Text] [Related]
37. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis. Macfarlane DP; Zou X; Andrew R; Morton NM; Livingstone DE; Aucott RL; Nyirenda MJ; Iredale JP; Walker BR Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E402-9. PubMed ID: 21119028 [TBL] [Abstract][Full Text] [Related]
38. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet. Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984 [TBL] [Abstract][Full Text] [Related]
39. Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. Okubo H; Sakoda H; Kushiyama A; Fujishiro M; Nakatsu Y; Fukushima T; Matsunaga Y; Kamata H; Asahara T; Yoshida Y; Chonan O; Iwashita M; Nishimura F; Asano T Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G911-8. PubMed ID: 24113768 [TBL] [Abstract][Full Text] [Related]
40. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]